{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:30:04Z","timestamp":1789777804806,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/149036\/2019"],"award-info":[{"award-number":["SFRH\/BD\/149036\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD), characterized by \u03b1-Synuclein aggregation and dopaminergic neuronal loss, has no current cure. Autophagy is critical for \u03b1-Synuclein clearance, yet its real-time dynamics remain challenging to assess in human-relevant systems. Here, we used live-cell imaging to assess autophagy within human neuronal cultures and midbrain organoids (hMOs) derived from induced pluripotent stem cells (iPSCs) of PD patients carrying a triplication of the \u03b1-Synuclein gene (3xSNCA). Using the LC3-Rosella dual-fluorescent reporter, we quantified autolysosomes dynamics in real time. In 3xSNCA neuronal cultures, we detected early autophagy defects. In 3xSNCA hMOs, reduced autolysosome area, increased total and phosphorylated \u03b1-Synuclein (pS129), and decreased electrophysiological activity were observed at 50 days of differentiation (DoD). By 70 DoD, autophagy impairment became more pronounced, overlapping with dopaminergic neuron dysfunction. These findings support the use of human iPSCs-derived models to study autophagy dysfunction in PD and demonstrate a temporal correlation between impaired autophagy, \u03b1-Synuclein pathology and neuronal degeneration.<\/jats:p>","DOI":"10.1038\/s41531-026-01330-x","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:48:09Z","timestamp":1774932489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Autophagy dysfunction in iPSCs-derived neurons and midbrain organoids carrying a SNCA triplication"],"prefix":"10.1038","volume":"12","author":[{"given":"Catarina","family":"Serra-Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Jarazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gomez-Giro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rosety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alise","family":"Zagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Frangenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Modamio-Chamarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Zuccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara","family":"Crist\u00f3v\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Christian","family":"Schwamborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804\u20132815 (1988).","journal-title":"J. Neurosci."},{"key":"1330_CR2","doi-asserted-by":"publisher","first-page":"167714","DOI":"10.1016\/j.jmb.2022.167714","volume":"435","author":"V Gao","year":"2023","unstructured":"Gao, V., Briano, J. A., Komer, L. E. & Burr\u00e9, J. Functional and Pathological Effects of \u03b1-Synuclein on Synaptic SNARE Complexes. J. Mol. Biol. 435, 167714 (2023).","journal-title":"J. Mol. Biol."},{"key":"1330_CR3","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science (80-) 276, 2045\u20132047 (1997).","journal-title":"Science (80-)"},{"key":"1330_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"1330_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz, J. J. et al. The New Mutation, E46K, of \u03b1-Synuclein Causes Parkinson and Lewy Body Dementia. Ann. Neurol. 55, 164\u2013173 (2004).","journal-title":"Ann. Neurol."},{"key":"1330_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez, P. et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 364, 1169\u20131171 (2004).","journal-title":"Lancet"},{"key":"1330_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. \u03b1-Synuclein Locus Triplication Causes Parkinson\u2019s Disease. Science (80-) 302, 841 (2003).","journal-title":"Science (80-)"},{"key":"1330_CR8","first-page":"546462","volume":"2015","author":"R Ferese","year":"2015","unstructured":"Ferese, R. et al. Four Copies of SNCA Responsible for Autosomal Dominant Parkinson\u2019s Disease in Two Italian Siblings. Parkinsons. Dis. 2015, 546462 (2015).","journal-title":"Parkinsons. Dis."},{"key":"1330_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer, M. et al. Comparison of Kindreds with Parkinsonism and \u03b1-Synuclein Genomic Multiplications. Ann. Neurol. 55, 174\u2013179 (2004).","journal-title":"Ann. Neurol."},{"key":"1330_CR10","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1074\/jbc.M010907200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky, V. N., Li, J. & Fink, A. L. Evidence for a Partially Folded Intermediate in \u03b1-Synuclein Fibril Formation. J. Biol. Chem. 276, 10737\u201310744 (2001).","journal-title":"J. Biol. Chem."},{"key":"1330_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14, 176 (2023).","journal-title":"Cell Death Dis"},{"key":"1330_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine, B. & Kroemer, G. uido Autophagy in the Pathogenesis of Disease. Cell 132, 27\u201342 (2008).","journal-title":"Cell"},{"key":"1330_CR13","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1007\/s12035-022-02897-1","volume":"59","author":"S Sahoo","year":"2022","unstructured":"Sahoo, S., Padhy, A. A., Kumari, V. & Mishra, P. Role of Ubiquitin\u2013Proteasome and Autophagy-Lysosome Pathways in \u03b1-Synuclein Aggregate Clearance. Mol. Neurobiol. 59, 5379\u20135407 (2022).","journal-title":"Mol. Neurobiol."},{"key":"1330_CR14","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.biocel.2004.02.013","volume":"36","author":"AE Majeski","year":"2004","unstructured":"Majeski, A. E. & Fred Dice, J. Mechanisms of chaperone-mediated autophagy. Int. J. Biochem. Cell Biol. 36, 2435\u20132444 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1330_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1371\/journal.pone.0005515","volume":"4","author":"M Xilouri","year":"2009","unstructured":"Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D. & Stefanis, L. Abberant \u03b1-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4, 16\u201320 (2009).","journal-title":"PLoS One"},{"key":"1330_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A. M., Stafanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy. Science (80-) 305, 1292\u20131295 (2004).","journal-title":"Science (80-)"},{"key":"1330_CR17","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1330_CR18","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay, B. et al. Pathogenic lysosomal depletion in Parkinson\u2019s disease. J. Neurosci. 30, 12535\u201312544 (2010).","journal-title":"J. Neurosci."},{"key":"1330_CR19","first-page":"1464","volume":"67","author":"JM Cooper","year":"2010","unstructured":"Cooper, J. M. et al. Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains. Arch. Neurol. 67, 1464\u20131472 (2010).","journal-title":"Arch. Neurol."},{"key":"1330_CR20","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1080\/15548627.2016.1214777","volume":"12","author":"M Xilouri","year":"2016","unstructured":"Xilouri, M. et al. Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats. Autophagy 12, 2230\u20132247 (2016).","journal-title":"Autophagy"},{"key":"1330_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41591-019-0739-1","volume":"26","author":"AH Laperle","year":"2020","unstructured":"Laperle, A. H. et al. iPSC modeling of young-onset Parkinson\u2019s disease reveals a molecular signature of disease and novel therapeutic candidates. Nat. Med. 26, 289\u2013299 (2020).","journal-title":"Nat. Med."},{"key":"1330_CR22","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.1520335113","volume":"113","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli, J. R., Zunke, F., Isacson, O., Studer, L. & Krainc, D. -Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc. Natl. Acad. Sci. USA. 113, 1931\u20131936 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1330_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","volume":"45","author":"A Bose","year":"2022","unstructured":"Bose, A., Petsko, G. A. & Studer, L. Induced pluripotent stem cells: a tool for modeling Parkinson\u2019s disease. Trends Neurosci 45, 608\u2013620 (2022).","journal-title":"Trends Neurosci"},{"key":"1330_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21238910","volume":"21","author":"R Zahumenska","year":"2020","unstructured":"Zahumenska, R. et al. Induced pluripotency: A powerful tool for in vitro modeling. Int. J. Mol. Sci. 21, 1\u201319 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1330_CR25","doi-asserted-by":"publisher","first-page":"20220040","DOI":"10.1098\/rsfs.2022.0040","volume":"12","author":"A Bhargava","year":"2022","unstructured":"Bhargava, A., Sandoval Castellanos, A. M., Shah, S. & Ning, K. An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders. Interface Focus 12, 20220040 (2022).","journal-title":"Interface Focus"},{"key":"1330_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nature10761","volume":"481","author":"DA Robinton","year":"2012","unstructured":"Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295\u2013305 (2012).","journal-title":"Nature"},{"key":"1330_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nmeth.4576","volume":"15","author":"N De Souza","year":"2018","unstructured":"De Souza, N. Organoids. Nat. Methods 15, 23 (2018).","journal-title":"Nat. Methods"},{"key":"1330_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo, J. et al. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. Cell Stem Cell 19, 248\u2013257 (2016).","journal-title":"Cell Stem Cell"},{"key":"1330_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel, A. S. et al. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem Cell Reports 8, 1144\u20131154 (2017).","journal-title":"Stem Cell Reports"},{"key":"1330_CR30","first-page":"1","volume":"2020","author":"X Hu","year":"2020","unstructured":"Hu, X. et al. Modeling Parkinson\u2019s Disease Using Induced Pluripotent Stem Cells. Stem Cells Int 2020, 1\u201315 (2020).","journal-title":"Stem Cells Int"},{"key":"1330_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.26166","volume":"90","author":"J Jo","year":"2021","unstructured":"Jo, J. et al. Lewy Body\u2013like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and \u03b1-Synuclein Mutations. Ann. Neurol. 90, 490\u2013505 (2021).","journal-title":"Ann. Neurol."},{"key":"1330_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/braincomms\/fcab223","volume":"3","author":"NV Mohamed","year":"2021","unstructured":"Mohamed, N. V. et al. Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy. Brain Commun 3, 1\u201321 (2021).","journal-title":"Brain Commun"},{"key":"1330_CR33","doi-asserted-by":"publisher","first-page":"103919","DOI":"10.1016\/j.mcn.2024.103919","volume":"128","author":"MN Muwanigwa","year":"2024","unstructured":"Muwanigwa, M. N. et al. Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson\u2019s disease. Mol. Cell. Neurosci. 128, 103919 (2024).","journal-title":"Mol. Cell. Neurosci."},{"key":"1330_CR34","doi-asserted-by":"publisher","unstructured":"Modamio, J. et al. Synaptic decline precedes dopaminergic neuronal loss in human midbrain organoids harboring a triplication of the SNCA gene. bioRxiv (2021) https:\/\/doi.org\/10.1101\/2021.07.15.452499.","DOI":"10.1101\/2021.07.15.452499"},{"key":"1330_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45917-2","volume":"9","author":"J Arias-Fuenzalida","year":"2019","unstructured":"Arias-Fuenzalida, J. et al. Automated high-throughput high-content autophagy and mitophagy analysis platform. Sci. Rep. 9, 9455 (2019).","journal-title":"Sci. Rep."},{"key":"1330_CR36","doi-asserted-by":"publisher","first-page":"e59252","DOI":"10.1371\/journal.pone.0059252","volume":"8","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt, P. et al. Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling. PLoS One 8, e59252 (2013).","journal-title":"PLoS One"},{"key":"1330_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5483\/BMBRep.2020.53.5.046","volume":"53","author":"S Kim","year":"2020","unstructured":"Kim, S., Choi, S. & Kang, D. Quantitative and qualitative analysis of autophagy flux using imaging. BMB Rep 53, 241\u2013247 (2020).","journal-title":"BMB Rep"},{"key":"1330_CR38","first-page":"1","volume":"6","author":"QP Su","year":"2016","unstructured":"Su, Q. P. et al. Vesicle Size Regulates Nanotube Formation in the Cell. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"1330_CR39","doi-asserted-by":"publisher","unstructured":"Smits, L. M. et al. Modeling Parkinson \u2019 s disease in midbrain-like organoids. npj Park. Dis. (2019) https:\/\/doi.org\/10.1038\/s41531-019-0078-4.","DOI":"10.1038\/s41531-019-0078-4"},{"key":"1330_CR40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","volume":"11","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin, C. & Neufeld, T. P. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion. Autophagy 11, 1437\u20131438 (2015).","journal-title":"Autophagy"},{"key":"1330_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bj\u00f8rk\u00f8y","year":"2005","unstructured":"Bj\u00f8rk\u00f8y, G. et al. p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603\u2013614 (2005).","journal-title":"J. Cell Biol."},{"key":"1330_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin, D. et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat. Commun. 13, 1\u201315 (2022).","journal-title":"Nat. Commun."},{"key":"1330_CR43","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1523\/JNEUROSCI.0610-22.2023","volume":"43","author":"C Pitcairn","year":"2023","unstructured":"Pitcairn, C., Murata, N., Zalon, A. J., Stojkovska, I. & Mazzulli, J. R. Impaired Autophagic-Lysosomal Fusion in Parkinson\u2019s Patient Midbrain Neurons Occurs through Loss of ykt6 and Is Rescued by Farnesyltransferase Inhibition. J. Neurosci. 43, 2615\u20132629 (2023).","journal-title":"J. Neurosci."},{"key":"1330_CR44","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ndorf, D. C. et al. IPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun. 5, (2014).","DOI":"10.1038\/ncomms5028"},{"key":"1330_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/emmm.201200215","volume":"4","author":"A S\u00e1nchez-Dan\u00e9s","year":"2012","unstructured":"S\u00e1nchez-Dan\u00e9s, A. et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease. EMBO Mol. Med. 4, 380\u2013395 (2012).","journal-title":"EMBO Mol. Med."},{"key":"1330_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2015.318","volume":"6","author":"LMA Oliveira","year":"2015","unstructured":"Oliveira, L. M. A. et al. Elevated \u03b1-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson\u2019s patient-derived induced pluripotent stem cells. Cell Death Dis 6, 1\u201313 (2015).","journal-title":"Cell Death Dis"},{"key":"1330_CR47","first-page":"1","volume":"9","author":"I Rosety","year":"2023","unstructured":"Rosety, I. et al. Impaired neuron differentiation in GBA-associated Parkinson\u2019s disease is linked to cell cycle defects in organoids. npj Park. Dis. 9, 1\u201316 (2023).","journal-title":"npj Park. Dis."},{"key":"1330_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44732-2","volume":"15","author":"G Morrone Parfitt","year":"2024","unstructured":"Morrone Parfitt, G. et al. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson\u2019s disease model. Nat. Commun. 15, 447 (2024).","journal-title":"Nat. Commun."},{"key":"1330_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8007","volume":"6","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin, C., Nagy, P., Juh\u00e1sz, G. & Neufeld, T. P. Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification. Nat. Commun. 6, 7007 (2015).","journal-title":"Nat. Commun."},{"key":"1330_CR50","doi-asserted-by":"crossref","unstructured":"Leupold, L., Sigutova, V., Gerasimova, E. & Regensburger, M. The Quest for Anti- \u03b1 -Synuclein Antibody Specificity \u2014 Lessons Learnt From Flow Cytometry Analysis. 13, 1\u201318 (2022).","DOI":"10.3389\/fneur.2022.869103"},{"key":"1330_CR51","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"SA Tanik","year":"2013","unstructured":"Tanik, S. A., Schultheiss, C. E., Volpicelli-Daley, L. A., Brunden, K. R. & Lee, V. M. Y. Lewy body-like \u03b1-synuclein aggregates resist degradation and impair macroautophagy. J. Biol. Chem. 288, 15194\u201315210 (2013).","journal-title":"J. Biol. Chem."},{"key":"1330_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001287","volume":"19","author":"AD Senol","year":"2021","unstructured":"Senol, A. D. et al. \u03b1-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. PLoS Biol 19, e3001287 (2021).","journal-title":"PLoS Biol"},{"key":"1330_CR53","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.25462","volume":"28","author":"B Dehay","year":"2013","unstructured":"Dehay, B. et al. Lysosomal impairment in Parkinson\u2019s disease. Mov. Disord. 28, 725\u2013732 (2013).","journal-title":"Mov. Disord."},{"key":"1330_CR54","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic, S. et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. USA. 110, E4016\u2013E4025 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1330_CR55","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0000000000002102","volume":"85","author":"JM Milber","year":"2015","unstructured":"Milber, J. M. et al. Parkinson disease and incidental Lewy body disease. Neurology 85, 1670\u20131679 (2015).","journal-title":"Neurology"},{"key":"1330_CR56","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/ars.2015.6343","volume":"24","author":"E Deas","year":"2016","unstructured":"Deas, E. et al. Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease. Antioxidants Redox Signal 24, 376\u2013391 (2016).","journal-title":"Antioxidants Redox Signal"},{"key":"1330_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00011-022-01676-x","volume":"72","author":"QK Lv","year":"2023","unstructured":"Lv, Q. K. et al. Role of \u03b1-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson\u2019s disease. Inflamm. Res. 72, 443\u2013462 (2023).","journal-title":"Inflamm. Res."},{"key":"1330_CR58","doi-asserted-by":"publisher","first-page":"1039780","DOI":"10.3389\/fnagi.2022.1039780","volume":"14","author":"R Zhu","year":"2022","unstructured":"Zhu, R., Luo, Y., Li, S. & Wang, Z. The role of microglial autophagy in Parkinson\u2019s disease. Front. Aging Neurosci. 14, 1039780 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1330_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi, I. et al. Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat. Commun. 11, 1386 (2020).","journal-title":"Nat. Commun."},{"key":"1330_CR60","doi-asserted-by":"publisher","first-page":"101870","DOI":"10.1016\/j.scr.2020.101870","volume":"46","author":"SL Nickels","year":"2020","unstructured":"Nickels, S. L. et al. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson\u2019s disease. Stem Cell Res 46, 101870 (2020).","journal-title":"Stem Cell Res"},{"key":"1330_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12397","volume":"5","author":"A Sargsyan","year":"2015","unstructured":"Sargsyan, A. et al. Rapid parallel measurements of macroautophagy and mitophagy in mammalian cells using a single fluorescent biosensor. Sci. Rep. 5, 1\u201311 (2015).","journal-title":"Sci. Rep."},{"key":"1330_CR62","doi-asserted-by":"publisher","first-page":"24610","DOI":"10.1074\/jbc.M413565200","volume":"280","author":"T Kouno","year":"2005","unstructured":"Kouno, T. et al. Solution structure of microtubule-associated protein light chain 3 and identification of its functional subdomains. J. Biol. Chem. 280, 24610\u201324617 (2005).","journal-title":"J. Biol. Chem."},{"key":"1330_CR63","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s42003-024-07273-4","volume":"7","author":"K Barmpa","year":"2024","unstructured":"Barmpa, K. et al. Modeling early phenotypes of Parkinson\u2019s disease by age-induced midbrain-striatum assembloids. Commun. Biol. 7, 1561 (2024).","journal-title":"Commun. Biol."},{"key":"1330_CR64","doi-asserted-by":"crossref","unstructured":"Zuccoli, E. et al. Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modeling. iScience 28, (2025).","DOI":"10.1101\/2025.04.17.649331"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01330-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:03:23Z","timestamp":1779667403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01330-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01330-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.J. and J.C.S. are cofounders and shareholders of OrganoTherapeutics soci\u00e9t\u00e9 \u00e0 responsabilit\u00e9 limit\u00e9e (SARL).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}